Karyopharm Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Insights

Karyopharm Therapeutics, Inc. (KPTI)

8.97 +0.81 (+9.93%) USD | NASDAQ | May 26, 16:00

9.15 +0.18 (+2.01%) After-Hours: 20:00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for KPTI.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Gilead Sciences, Inc.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade
Altimmune, Inc.	Upgrade
Cellectar Biosciences, Inc.	Upgrade
Ocugen, Inc.	Upgrade